Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan

Clinical Trials, Metastatic Castration Resistant Prostate Cancer (MCRPC)

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT06099093
Phase: PHASE4
Trial Summary: The purpose of this research study is to see how well an imaging test, called 18FDCFPyL prostate specific membrane antigen (PSMA) positron emission tomography (PET), can show the extent of prostate ca – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Brigham and Women’s Hospital
Acronym:

Pin It on Pinterest